Conmed reports Q4 adjusted EPS $1.43, consensus $1.32

Reports Q4 revenue $373.2M, consensus $366.88M. “Our fourth quarter results reflect steady execution across the business as well as progress on our operational initiatives,” said Patrick J. Beyer, CONMED’s (CNMD) President and Chief Executive Officer. “As we begin 2026 with a sharpened strategic focus, we remain disciplined in our operating approach and confident in the long-term potential of our key growth drivers in minimally invasive surgery, smoke evacuation, and orthopedic soft tissue repair.”